Form D Explorer

Source evidence

Epicrispr Biotechnologies, Inc. · 0002151604-26-000001

D filed Aug. 26, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
SOUTH SAN FRANCISCO
street1
7000 SHORELINE COURT, STE 100
zipCode
94080
entityName
Epicrispr Biotechnologies, Inc.
entityType
Corporation
stateOrCountry
CA
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold176754406number176754406/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount212755230number212755230/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count47number47/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 95bf2fae0cbb585c1d4f7ecfd58a7c7876f59a58473517c9d6526544f5fa4d85. This proves extraction identity, not the accuracy of the filer's claims.